Churchill Hospital

Headington OX3 9DS

0 studies enrolling now · 4 studies all time

What they study most

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, Androgen-Resistant Prostatic Cancer, Hormone Refractory Prostatic Cancer, Immune Checkpoint Inhibitor, Immunotherapy, Inhibitory Checkpoint Molecule, Liposarcoma, Dedifferentiated, Prostate Cancer Recurrent, Solid Cancer, Type 1 Diabetes

Studies at this site

• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes — Running, not enrolling
• A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer — Completed
• Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed